Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay

Cancer Immunology, Immunotherapy

Volumn 60, Issue 4, 2011, Pages 479-485

  Pacini, Stefania ^a   Morucci, Gabriele ^a   Punzi, Tiziana ^a   Gulisano, Massimo ^a   Ruggiero, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Angiogenesis; cAMP; GcMAF; Peripheral blood human mononuclear cells

Indexed keywords

CYCLIC AMP; GC PROTEIN DERIVED MACROPHAGE ACTIVATING FACTOR; HEPARIN; MACROPHAGE ACTIVATING FACTOR; PROSTAGLANDIN E1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; ASSAY; CANCER CELL; CELL PROLIFERATION; CHICK EMBRYO CHORIOALLANTOIC MEMBRANE ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STABILITY; DRUG STORAGE; EMBRYO; HUMAN; HUMAN CELL; MITOGENESIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; ROOM TEMPERATURE;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL PROLIFERATION; CHICK EMBRYO; CYCLIC AMP; DRUG STABILITY; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGE-ACTIVATING FACTORS; NEOVASCULARIZATION, PATHOLOGIC; VITAMIN D-BINDING PROTEIN;

EID: 79953774678     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0953-7     Document Type: Article

References (39)

1. Yamamoto N, Naraparaju VR (1997) Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor. Cancer Res 47:2187-2192 (Pubitemid 27247036)
2. Nagasawa H, Uto Y, Sasaki H, Okamura N, Murakami A, Kubo S, Kirk KL, Hori H (2005) Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res 25:3689-3695 (Pubitemid 41658440)
3. Yamamoto N, Naraparaju VR, Urade M (1997) Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients. Cancer Res 57:295-299 (Pubitemid 27036609)
4. Kanda S, Mochizuki Y, Miyata Y, Kanetake H, Yamamoto N (2002) Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. J Natl Cancer Inst 94:1311-1319
5. Kisker O, Onizuka S, Becker CM, Fannon M, Flynn E, D'Amato R, Zetter B, Folkman J, Ray R, Swamy N, Pirie-Shepherd S (2003) Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia 5:32-40 (Pubitemid 36151056)
6. Kalkunte S, Brard L, Granai CO, Swamy N (2005) Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf. Angiogenesis 8:349-360
7. Nonaka K, Onizuka S, Ishibashi H, Uto Y, Hori H, Nakayama T, Matsuura N, Kanematsu T, Fujioka H (2010) Vitamin D binding protein-macrophage activating factor inhibits HCC in SCID mice. J Surg Res Sep 18 [Epub ahead of print]
8. Iida S, Yamamoto K, Irimura T (1999) Interaction of human macrophage C-type lectin with O-linked N-acetylgalactosamine residues on mucin glycopeptides. J Biol Chem 274:10697-10705
9. W81XWH-04-1-0010. Treatment of prostate cancer with a DBP-MAF-vitamin D complex to target angiogenesis and tumorigenesis. Michael W. Fannon, Ph.D. University of Kentucky Research Foundation Lexington, Kentucky 40506-0057. U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012. (Approved for Public Release; Distribution Unlimited)
10. Tsopanoglou NE, Haralabopoulos GC, Maragoudakis ME (1994) Opposing effects on modulation of angiogenesis by protein kinase C and cAMP-mediated pathways. J Vasc Res 31:195-204 (Pubitemid 24210910)
11. Yamamoto N, Ushijima N, Koga Y (2009) Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). J Med Virol 81:16-26
12. Link RP, Perlman KL, Pierce EA, Schnoes HK, DeLuca HF (1986) Purification of human serum vitamin D-binding protein by 25-hydroxyvitamin D3-Sepharose chromatography. Anal Biochem 157:262-269 (Pubitemid 16027061)
13. Yamamoto N, Kumashiro R (1993) Conversion of vitamin D3 binding protein (Group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells. J Immun 151:2794-2902
14. Naraparaju VR, Yamamoto N (1994) Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages. Immunol Lett 43:143-148
15. Yamamoto N (1996) Structural definition of a potent macrophage activating factor derived from vitamin D3-binding protein with adjuvant activity for antibody production. Mol Immunol 33:1157-1164
16. Hayon T, Dvilanski A, Shpilberg O, Nathan I (2003) Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia. Leuk Lymphome 44:1957-1962 (Pubitemid 37369631)
17. Pacini S, Punzi T, Morucci G, Gulisano M, Ruggiero M (2009) A paradox of cadmium: a carcinogen that impairs the capability of human breast cancer cells to induce angiogenesis. J Environ Pathol Toxicol Oncol 28:85-88
18. Sharma S, Ghoddoussi M, Gao P, Kelloff GJ, Steele VE, Kopelovich L (2001) A quantitative angiogenesis model for efficacy testing of chemopreventive agents. Anticancer Res 21:3829-3837 (Pubitemid 34229248)
19. Santos-Alvarez J, Goberna R, Sánchez-Margalet V (1999) Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194:6-11 (Pubitemid 29283971)
20. Vannucchi S, Pasquali F, Chiarugi VP, Ruggiero M (1991) Heparin inhibits A431 cell growth independently of serum and EGF mitogenic signalling. FEBS Lett 281:141-144
21. Cavari S, Ruggiero M, Vannucchi S (1993) Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts. Cell Biol Int 17:781-786 (Pubitemid 23280363)
22. Lulli M, Di Gesualdo F, Witort E et al. (2010) Cell death: physiopathological and therapeutic implications. Cell Death Dis. doi:10.1038/cddis.2010.8
23. Takahashi HK, Liu K, Wake H, Mori S, Zhang J, Liu R, Yoshino T, Nishibori M (2009) Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human peripheral blood mononuclear cells. J Pharmacol Exp Ther 331:656-670
24. Giles FJ (2002) The emerging role of angiogenesis inhibitors in hematologic malignancies. Oncology 16:23-29
25. Senchina DS, Shah NB, Doty DM, Sanderson CR, Hallam JE (2009) Herbal supplements and athlete immune function - what's proven, disproven, and unproven? Exerc Immunol Rev 15:66-106
26. Yamamoto N, Naraparaju VR, Moore M, Brent LH (1997) Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus. Clin Immunol Immunopathol 82:290-298 (Pubitemid 27128316)
27. Yamamoto N, Suyama H, Yamamoto N (2008) Immunotherapy for prostate cancer with Gc protein-derived macrophage-activating factor, GcMAF. Transl Oncol 1:65-72
28. Yamamoto N, Suyama H, Nakazato H, Yamamoto N, Koga Y (2008) Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. Cancer Immunol Immunother 57:1007-1016
29. Yamamoto N, Suyama H, Yamamoto N, Ushijima N (2008) Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). Int J Cancer 122:461-467 (Pubitemid 350234736)
30. Yamamoto N, Naraparaju VR, Asbell SO (1996) Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients. Cancer Res 56:2827-2831 (Pubitemid 26175743)
31. Greco M, Mitri MD, Chiriacò F, Leo G, Brienza E, Maffia M (2009) Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity. Cancer Lett 283:222-229
32. Panova-Noeva M, Falanga A (2010) Treatment of thromboembolism in cancer patients. Expert Opin Pharmacother 11:2049-2058
33. Cao Y (2010) Angiogenesis: what can it offer for future medicine? Exp Cell Res 316:1304-1308
34. Rusnati M, Presta M (2002) HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis 5:141-151 (Pubitemid 36687517)
35. Ribatti D (2008) Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Int Rev Cell Mol Biol 270:181-224
36. Ribatti D (2010) The chick embryo chorioallantoic membrane as an in vivo assay to study antiangiogenesis. Pharmaceuticals 3:482-513
37. http://www.gcmaf.eu/info/. Accessed 08 October 2010
38. http://immunemedicine.com/available-therapies/gcmaf/. Accessed 08 October 2010
39. http://www.gcmaf.nl. Accessed 08 October 2010